MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia

    S. Gorcenco, E. Kafantari, J. Wallenius, C. Karremo, E. Alinder, S. Dobloug, M. Landqvist Waldö, E. Englund, H. Ehrencrona, K. Wictorin, K. Karrman, A. Puschmann (Lund, Sweden)

    Objective: In this study, we aimed to examine clinically and genetically a patient series with ataxia from southern Sweden with known or unknown genetic causes.…
  • 2023 International Congress

    Opicapone’s Effects on Progression Scales in Relation to the 9-Symptom Wearing-off Questionnaire: the OPTIPARK Study

    D. Martins, A. Lees, H. Reichmann, J-F. Rocha (Coronado, Portugal)

    Objective: This study aims to evaluate changes in Parkinson’s disease (PD) progression scales in patients with PD and motor fluctuations (MF) treated with once-daily opicapone…
  • 2023 International Congress

    Beta is jumping the queue: Temporal overlap of beta desynchronization and synchronization during rapid movement changes

    L. Winkler, M. Butz, A. Sharma, J. Vesper, A. Schnitzler, P. Fischer, J. Hirschmann (Düsseldorf, Germany)

    Objective: Movement initiation and termination are often studied in isolation. Here we shed light on the neural processes underlying rapid changes of ongoing movements, where…
  • 2023 International Congress

    Current practices for ‘timing’ of physical therapy in Parkinson’s Disease: ‘Burst vs. Spaced’

    J. Lelaurin, R. Salloum, M. Okun (Gainesville, USA)

    Objective: To assess current practices for timing of physical therapy (PT) in Parkinson’s disease (PD). Background: Most persons with Parkinson disease (PD) face increasing mobility…
  • 2023 International Congress

    Clinical severity in Parkinson’s disease is determined by decline in cortical compensation

    M. Johansson, I. Toni, R. Kessels, B. Bloem, R. Helmich (Nijmegen, Netherlands)

    Objective: We tested whether inter- and intra-individual differences in clinical severity are determined by cortical compensation, and not just by basal ganglia dysfunction. Background: Motor…
  • 2023 International Congress

    Diffuse cerebellar edema in acute anti-Yo positive paraneoplastic cerebellar degeneration: A case report

    T. Dang, K. Vo, U. Ha, Q. Pham, C. Phan, T. Tran (HO CHI MINH, Viet Nam)

    Objective: To report a case of acute anti-Yo positive paraneoplastic cerebellar degeneration (PCD) with atypical brain MRI findings. Background: PCD is a rare disease but…
  • 2023 International Congress

    Clinical Improvement and drastic reduction of Equivalent Dose of Levodopa (LEDD) in an Advanced Parkinson’s Disease Patient after Levodopa/Entacapone/Carbidopa Intestinal Gel (LECIG) Treatment

    G. Tabar Comellas, MI. Morales Casado, JC. Segundo-Rodríguez, N. Lopez Ariztegui (Toledo, Spain)

    Objective: Describe a patient in which after starting continuous infusion of LECIG a large reduction of the LEDD  is achieved. Background: Gastroparesis (GP) is one…
  • 2023 International Congress

    Neuropalliative communication curriculum: A review of the literature and needs assessment

    K. Block, A. Hiller, N. Leavell, S. Sorge (Portland, USA)

    Objective: We aim to improve neuropalliative education in neurology trainees by creating a reproducible didactic curriculum targeting specific communication techniques using case-based sensitive scenarios commonly…
  • 2023 International Congress

    Impact of dopamine replacement therapy on shame in Parkinson’s disease patients

    S. Catalano Chiuvé, D. Benis, A. Zulet, P. Krack, V. Fleury (Geneva, Switzerland)

    Objective: This study aims to investigate the effect of dopaminergic replacement therapy (DRT) on shame using emotional dynamic rating scales during ON and OFF-DRT states.…
  • 2023 International Congress

    Identifying neural biomarkers of motivated behavior in Parkinson’s disease using sensing-capable DBS devices

    N. Provenza, S. Rajesh, N. Diab, S. Reddy, B. Lamichhane, A. Sabharwal, J. Herron, Y. Gazes, C. Le Heron, S. Sheth, N. Vanegas-Arroyave (Houston, USA)

    Objective: To investigate neural correlates of motivated, goal directed behavior within the basal ganglia. Background: Apathy is a common and debilitating complication of Parkinson’s disease…
  • « Previous Page
  • 1
  • …
  • 165
  • 166
  • 167
  • 168
  • 169
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley